Associations of site-specific CD4+-T-cell hypomethylation within CD40-ligand promotor and enhancer regions with disease activity of women with systemic lupus erythematosus.

CONCLUSION: Site-specific hypomethylation of the CD40L promotor in CD4+-T-cells show associations with disease activity in female SLE patients. PMID: 33081589 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/33081589?dopt=Abstract

Source: Lupus - October 20, 2020 Category: Rheumatology Authors: Vordenbäumen S, Rosenbaum A, Gebhard C, Raithel J, Sokolowski A, Düsing C, Chehab G, Richter JG, Brinks R, Rehli M, Schneider M Tags: Lupus Source Type: research

More News: Genetics | Lupus | Rheumatology | Study | Women